Supernus Pharmaceuticals, Inc. Business Finance Contracts & Agreements

60 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan Performance Share Unit Award Agreement
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2025
Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Agreement
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2024
Supernus Pharmaceuticals, Inc. Non-Statutory Time-Based Stock Option Agreement under 2021 Equity Incentive Plan
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2024
Supernus Pharmaceuticals, Inc. Time-Based Incentive Stock Option Agreement under 2021 Equity Incentive Plan
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2024
Exhibit 10.1 Credit Line Agreement between UBS Bank USA and Supernus Pharmaceuticals, Inc. dated as of February 8, 2023
Credit Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2023
Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Supernus Pharmaceuticals, Inc. Non-Statutory Time-Based Stock Option Agreement under 2021 Equity Incentive Plan
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Supernus Pharmaceuticals, Inc. Time-Based Incentive Stock Option Agreement (2021 Equity Incentive Plan)
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Purchase and Sale Agreement between Supernus Pharmaceuticals Inc. and Rune Healthcare Limited (June 9, 2006)
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Asset Purchase and Contribution Agreement among Supernus Pharmaceuticals, Inc., Shire Laboratories Inc., and Shire plc (December 22, 2005)
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Supernus Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement for Non-Employee Directors
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Supernus Pharmaceuticals Announcement of Presentation at 2019 Cantor Global Healthcare Conference
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Supernus Pharmaceuticals Announcement of September 2019 Healthcare Conference Presentations
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Supernus Pharmaceuticals Second Quarter 2019 Earnings Conference Call Announcement
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Warrant Transaction Confirmation between JPMorgan Chase Bank, N.A., London Branch and Supernus Pharmaceuticals, Inc.
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Warrant Transaction Confirmation between Bank of America, N.A. and Supernus Pharmaceuticals, Inc. dated March 15, 2018
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Warrant Transaction Confirmation between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc.
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Confirmation of Additional Convertible Bond Hedge Transaction between JPMorgan Chase Bank, N.A., London Branch and Supernus Pharmaceuticals, Inc.
Financing Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Confirmation of Additional Convertible Bond Hedge Transaction between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc.
Financing Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Warrant Confirmation Agreement between JPMorgan Chase Bank, N.A., London Branch and Supernus Pharmaceuticals, Inc. dated March 14, 2018
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Warrant Transaction Confirmation between Bank of America, N.A. and Supernus Pharmaceuticals, Inc.
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Warrant Transaction Confirmation between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc.
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction Confirmation between JPMorgan Chase Bank, N.A., London Branch and Supernus Pharmaceuticals, Inc.
Financing Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction Confirmation between Bank of America, N.A. and Supernus Pharmaceuticals, Inc.
Financing Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Convertible Bond Hedge Transaction Confirmation between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc.
Financing Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Indenture Agreement for 0.625% Convertible Senior Notes due 2023 between Supernus Pharmaceuticals, Inc. and Wilmington Trust, National Association
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Supernus Pharmaceuticals, Inc. $350,000,000 0.625% Convertible Senior Notes Due 2023 Purchase Agreement with Jefferies LLC, J.P. Morgan Securities LLC, and Cowen and Company, LLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Term Sheet Agreement for Settlement and License between Supernus Pharmaceuticals, Inc. and Actavis Laboratories, FL, Inc., Actavis Pharma, Inc., and Watson Laboratories, Inc.
Term Sheets
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2017
Royalty Acquisition Agreement between Supernus Pharmaceuticals, Inc. and HealthCare Royalty Partners
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2014
Security Agreement between Supernus Pharmaceuticals, Inc. and Healthcare Royalty Partners III, L.P. (July 1, 2014)
Security Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
Royalty Interest Acquisition Agreement between Supernus Pharmaceuticals, Inc. and HealthCare Royalty Partners III, L.P. (July 1, 2014)
Assignment Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2014
First Supplemental Indenture to 7.5% Convertible Senior Secured Notes Due 2019 – Supernus Pharmaceuticals, Inc. and U.S. Bank National Association
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
Underwriting Agreement between Supernus Pharmaceuticals, Inc. and Underwriters (Jefferies, Piper Jaffray, Cowen) – 2012 Common Stock Offering
Underwriting Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
Amendment No. 2 to Stock Restriction Agreement by Supernus Pharmaceuticals, Inc. and Investors
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Supernus Pharmaceuticals, Inc. Stock Restriction Agreement with Holders and Investors (2005)
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Amendment No. 2 to Investor Rights Agreement by and among Supernus Pharmaceuticals, Inc. and Certain Investors
Investor Rights Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
Supernus Pharmaceuticals, Inc. 2012 Employee Stock Purchase Plan
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Supernus Pharmaceuticals, Inc. Non-Statutory Time-Based Stock Option Agreement under 2012 Equity Incentive Plan
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Supernus Pharmaceuticals, Inc. Time-Based Incentive Stock Option Agreement under 2012 Equity Incentive Plan
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Supernus Pharmaceuticals, Inc. 2012 Equity Incentive Plan
Equity Distribution Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012